Evidence map›Paper›PMID 41272772›Full record

ArticleJournal of nanobiotechnology2025

Gut microbiome restoring biogenic ferritin mineral as an effective oral iron supplement for iron deficiency anemia.

Yingchun Yang, Luqiu Yang, Rong Yang, Fangqing Deng, Qing Tian, Zhaoxiang Yu, Lianbing Zhang

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Nutrients · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yingchun Yang *Department of Gastroenterology, the First Affiliated Hospital of Xi'an Medical University, Xi'an, 710077, China.
Luqiu Yang *School of Life Sciences, Northwestern Polytechnical University, Xi'an, 710072, China.
Rong YangSchool of Life Sciences, Northwestern Polytechnical University, Xi'an, 710072, China.
Fangqing DengSchool of Life Sciences, Northwestern Polytechnical University, Xi'an, 710072, China.
Qing TianSchool of Life Sciences, Northwestern Polytechnical University, Xi'an, 710072, China.
Zhaoxiang YuDepartment of Gastroenterology, the First Affiliated Hospital of Xi'an Medical University, Xi'an, 710077, China. yuzhaoxiang@xiyi.edu.cn.
Lianbing ZhangSchool of Life Sciences, Northwestern Polytechnical University, Xi'an, 710072, China. lbzhang@nwpu.edu.cn.

Funding

China Postdoctoral Science Foundation 2024M754229National Natural Science Foundation of China 31971315
6 · The paper itself

Abstract

Traditional iron supplements for iron deficiency anemia (IDA) have several limitations, including suboptimal absorption, gastrointestinal discomfort, and concerns regarding long-term safety. In this study, we synthesized monodisperse 6-line ferrihydrite as an innovative iron supplement, featuring a structure analogous to the natural "iron core" present in ferritin. Notably, 6-line ferrihydrite (6-Fh) was internalized by Caco-2 cells via a process independent of divalent metal transporter 1 (DMT1). Additionally, its stability as nanoparticles within the gastrointestinal tract prevents the irritation typically associated with metal ions, thereby significantly enhancing iron utilization efficiency. Consequently, compared to FeSO₄ (a traditional oral iron supplement), 6-Fh effectively stabilized cellular free iron with low ROS toxicity and high biosafety, thereby effectively maintaining intestinal barrier integrity and avoiding liver injury. Furthermore, it restored intestinal dysbiosis caused by IDA and increased the proportion of beneficial bacterial strains, which was superior to FeSO₄. Characterized by low toxicity, efficient cellular absorption, intestinal stability, and superior iron supplementation efficacy compared with conventional iron supplements, 6-Fh demonstrates compelling therapeutic advantages and holds great promise for medical applications.

Indexed as

Anemia, Iron-DeficiencyFerric CompoundsFerritinsGastrointestinal MicrobiomeIronAdministration, OralAnimalsCaco-2 CellsDietary SupplementsDysbiosisHumansMaleMiceNanoparticlesFerric Compoundsferric oxyhydroxideFerritinsIronDMT1FerrihydriteGut microbiomeOral iron supplementation

Identifiers

PMID41272772
PMCPMC12639797

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.